|
|
Volumn 5, Issue 3 SPEC.ISS., 2004, Pages 21-
|
|
Three obstacles which confronted the development of compactin
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CHOLESTEROL;
COMPACTIN;
HISTAMINE H2 RECEPTOR ANTAGONIST;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
MEVALONIC ACID;
PRAVASTATIN;
ACHIEVEMENT;
CHOLESTEROL METABOLISM;
CHOLESTEROL SYNTHESIS;
CONFERENCE PAPER;
CRYSTAL;
DIET;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MEGADOSE;
DRUG RESEARCH;
DRUG TARGETING;
FEEDING;
HUMAN;
HYPERCHOLESTEROLEMIA;
IN VIVO STUDY;
LIVER CELL;
LYMPHOMA;
MUCOSA;
NONHUMAN;
PATIENT;
PRIORITY JOURNAL;
SOLUBILITY;
TOXICITY;
|
|
EID: 85057633523
PISSN: 15675688
EISSN: None
Source Type: Journal
DOI: 10.1016/j.atherosclerosissup.2004.08.020 Document Type: Conference Paper |
|
Times cited : (3)
|
|
References (0)
|